Presentation of RHAPSODY in Endocrinology, Diabetes & Metabolism

"RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes", a collaborative work between Janssen and ULUND resulting in a comprehensive 10 Minutes tutorial just published in Endocrinology, Diabetes & Metabolism

Stacks Image 47
Stacks Image 398
Stacks Image 51
Stacks Image 349
This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking (www.imi.europa.eu) under grant agreement No 115881. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 16.0097-2.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.